Sheba Medical Center marks a Phase 2 healthy ageing record completed

Bethesda, Maryland, 13 October 2026 — The ClinicalTrials.gov registry record with identifier NCT07871799, a Phase 2 interventional study sponsored by Sheba Medical Center, was last updated on 13 October 2026 and carries the overall status completed.

The record was returned by a registry search on the intervention term semaglutide, which matched 781 records in total on the day this wire was pulled. The Gazette reports the match, not an inference about what the entry contains.